Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma

Interleukin-6 (IL-6) can induce therapeutic resistance for several cancer agents currently used to treat classical Hodgkin lymphoma (cHL). We aimed to investigate whether the presence of IL-6(+) leukocytes and IL-6(+) Hodgkin-Reed-Sternberg (HRS) cells in the tumor microenvironment (TME) was associa...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Blood Adv
Main Authors: Gholiha, Alex Reza, Hollander, Peter, Glimelius, Ingrid, Hedstrom, Gustaf, Molin, Daniel, Hjalgrim, Henrik, Smedby, Karin E., Hashemi, Jamileh, Amini, Rose-Marie, Enblad, Gunilla
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Hematology 2021
Assuntos:
Lymphoid Neoplasia
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7993098/
https://ncbi.nlm.nih.gov/pubmed/33720338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020003664
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares